Clinical trials
Phase 1/2 Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
448 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 8 |
| 2001 | 5 |
| 2002 | 7 |
| 2003 | 7 |
| 2004 | 11 |
| 2005 | 12 |
| 2006 | 16 |
| 2007 | 14 |
| 2008 | 13 |
| 2009 | 17 |
| 2010 | 24 |
| 2011 | 20 |
| 2012 | 19 |
| 2013 | 19 |
| 2014 | 17 |
| 2015 | 14 |
| 2016 | 16 |
| 2017 | 18 |
| 2018 | 16 |
| 2019 | 28 |
| 2020 | 9 |
| 2021 | 23 |
| 2022 | 21 |
| 2023 | 31 |
| 2024 | 17 |
| 2025 | 16 |
| 2026 | 19 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 176 |
| Terminated | 83 |
| Recruiting | 67 |
| Unknown status | 56 |
| Active, not recruiting | 27 |
| Withdrawn | 18 |
| Not yet recruiting | 16 |
| Suspended | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 18 |
| M.D. Anderson Cancer Center | 12 |
| National Cancer Institute (NCI) | 12 |
| Fred Hutchinson Cancer Center | 11 |
| GlaxoSmithKline | 11 |
| Celgene | 8 |
| H. Lee Moffitt Cancer Center and Research Institute | 7 |
| Hackensack Meridian Health | 7 |
| Amgen | 6 |
| Incyte Corporation | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 448 |
| Neoplasms, Plasma Cell | 64 |
| Recurrence | 62 |
| Lymphoma | 45 |
| Lymphoma, Non-Hodgkin | 45 |
| Hodgkin Disease | 41 |
| Leukemia, Myeloid, Acute | 40 |
| Leukemia | 39 |
| Myelodysplastic Syndromes | 34 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 32 |
Trials
Showing 76 to 100 of 448. Each trial links to its page on Pharma Observatory.
348 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.